View Cart
Global Information, Inc.
US:
+1-860-674-8796
EU:
+32-2-535-7543
SG:
+65-6223-2436
Home
|
Category
|
Publishers
|
Custom Research
|
E-mail Alert
|
About Us
|
Contact Us
|
Site Map
|
Pharmaceutical
Drug Discovery
Drug Delivery System
Veterinary Medicine
Bone Disease Treatment
Obesity Treatment
Generic Drugs
OTC Drug
Prescription Drugs
Vaccines
Regulation
Cancer
Diabetes
Infection Disease
Mental Disease
Pharmaceutical Companies
Neurodegenerative Disease
View All Categories
Home
>
Category
>
Pharmaceutical
>
Market Research Report
A Survey of Private Companies Active in CNS & PNS Drug R&D
Published by
Startupguys Ltd
Published
2006/03
Content info
359 Pages
Product code
SGUY37449
Price
From
US $ 1820
US $ 1820
PDF & Excel File by E-mail (1-5 User License)
US $ 2743
PDF & Excel File by E-mail (Corporate Use License)
How to Order?
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Table of Contents
COMPANY DIRECTORY
Ablynx
Accera Pharmaceuticals
AC Immune
Acorda Therapeutics
ActivBiotics
Acumen Pharmaceuticals
Addex Pharmaceuticals
Aderis Pharmaceuticals
Aegera Therapeutics
Affectis Pharmaceuticals
AFFiRiS
AGY Therapeutics
Algos Therapeutics
Amsterdam Molecular Therapeutics
Apeiron Biologics
Arakis (Sosei Subsidiary)
Argolyn
ArmaGen Technologies
Asilomar Pharmaceuticals
Athersys
ATUKA
Auris Medical
Avera Pharmaceuticals
Axaron Bioscience
Axon Neuroscience
Azevan Pharmaceuticals
Bayhill Therapeutics
Berlex Laboratories (Schering Affiliate)
Bicoll
Bioalvo
Bioarctic Neuroscience
Bioaxone Therapeutic
Biocortech
Biofrontera AG
BiolineRX
BIOTECON Therapeutics (Analyticon Subsidiary)
Biovex
Boehringer-Ingelheim GmbH
Brainbits
Braincells
Brainsgate
Britannia Pharmaceutical (Forum Bioscience Subsidiary)
Cambridge Biotechnology (Biovitrum Subsidiary)
Cambridge Laboratories
Cannasat Therapeutics
Capsant Neurotechnologies
Cara Therapeutics
Carlsson Research
Cellzome
CeNeRx BioPharma
Cerebricon
Ceregene
Cerimon Pharmaceuticals
Chiesi Group / Chiesi Farmaceutici S.p.A.
CNAssays
Cognetix
Cognitive Pharmaceuticals
Cognosci
CoLucid Pharmaceuticals
Conogenetix Bioscience
Curidium
Daniolabs
Dexcel Pharma
D-Pharm
Drug Abuse Sciences
Elbion
ENCEPHARM
eNOS Pharmaceuticals
EnVivo Pharmaceuticals
ESBA Tech
Ester Neurosciences
Esteve
Fabre-Kramer Pharmaceuticals
FAN
Faust Pharmaceuticals
Galenea
Gemacbio
Grunenthal
Hamilton Pharmaceuticals
Helicon Therapeutics
Howard Associates
Hunter-Fleming
Hypnion
i3 Research (Ingenix Subsidiary)
Icogenex
Indena
Ingenium Pharmaceuticals
Intra-Cellular Therapies
Janssen Pharmaceutica (J&J Subsidiary)
Jazz Pharmaceuticals
JDS Pharmaceuticals
JSW Research
Juvantia Pharma
Kadmus Pharmaceuticals
KAI Pharmaceuticals
KeyNeurotek
Kinexis
Kosei (Sosei Subsidiary)
Krenitsky Pharmaceuticals
Marinus Pharmaceuticals
Medexis Biotech (Gerolymatos Subsidiary)
Medimod Pharmacology Services
Medpointe
Meltec
MIICRO
Molecular Synthetics
MOTAC Neuroscience / MOTAC Cognition
M's Science Corporation
Muscagen
Nautilus Biotech
Nanodel Technologies
Neuraxo Biotec
Neuraxon
Neurim Pharmaceuticals
Neurion Pharmaceuticals
Neuro3D
Neurobiomed
Neurobiotec
NeuroCure
Neurodetective
NeuroDigm
Neurofit
NeuroGesX
NeuroInvestigations
Neurology Clinical Research
Neurome
NeuroMed Technologies
Neuromics
Neuromolecular Pharmaceuticals
Neuronax
NeuroNova
Neuronyx
Neuropharma (Zeltia Subsidiary)
Neuroprofile
NeuroProgen
Neuroserve
Neurosolutions (Neurodiscovery subsidiary)
NeuroSurvival Technologies
Neurotargets
Neurotech
Neurotune (Prionics Spinoff)
Newneural
Newron Pharmaceuticals
NiKem Research
Novasite Pharmaceuticals
NsGene (Neurosearch Spinoff)
Nura
Nyxis Neurotherapies
Organon International (Subsidiary of Akzo Nobel)
Oryx Pharmaceuticals
Ovation Pharmaceuticals
PainCeptor Pharma Corporation
Panacea Pharmaceuticals
Paradigm Therapeutics
Paratek Pharmaceuticals
Pathogenics (filed for OTC Listing)
Pharmaxon
Pharmidex
Phase 2 Discovery
Pherin Pharmaceuticals
PragmaPharm
Predix Pharmaceuticals
Priosense
Probiodrug
Proneuron Biotechnologies
ProteoTech
Psychiatric Genomics
PsychoGenics
Psyncro
Purdue Pharma (Mundipharma/Napp)
Reata Pharmaceuticals
reMYND
RetinaPharma Technologies
Rinat Neuroscience
Rivanna Pharmaceuticals
Rottapharm Group
RxGen
Saegis Pharmaceuticals
Santhera Pharmaceuticals
Scion Pharmaceuticals
Senexis
Siena Biotech
Sigma-Tau Pharmaceuticals / Biofutura Pharma
Solstice Neurosciences
Somerset Pharmaceuticals
Sound Pharmaceuticals
Synaptic Systems
Targacept (plans IPO)
Tetragenex Pharmaceuticals
The Genetics Company
Theraptosis
Torreypines Therapeutics
Trophos
Vanda Pharmaceuticals
Vela Pharmaceuticals
Ventana Clinical Research
Verne Mendel Medical
Vistagen Therapeutics
Voyager Pharmaceuticals
Xenome
Xenon Pharmaceuticals
Xention Discovery
Xigen Pharmaceuticals
Xsira Pharmaceuticals
Xytis Pharmaceuticals
Yaupon Therapeutics
Zapaq
Zyentia
Zygogen
Related Report
Alzheimer disease - new drugs, markets and companies
Dealmaking and Industry Outlook: Neurological Disease
Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
Neuroprotection - Drugs, Markets and Companies
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
Please inform me when related publications are released
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.